<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615535</url>
  </required_header>
  <id_info>
    <org_study_id>2015P002184</org_study_id>
    <nct_id>NCT02615535</nct_id>
  </id_info>
  <brief_title>Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury</brief_title>
  <official_title>Neurofeedback-enhanced Mindfulness Meditation for the Treatment of Affective and Attentional Disturbances in Patients With Traumatic Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spaulding Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InteraXon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Spaulding Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spaulding Rehabilitation Hospital is conducting a research study evaluating the effectiveness
      of the brain-training product, MUSE, an EEG-guided neurofeedback device designed to assist in
      cultivating a relaxed, attentive state of mind during meditation. The investigators study
      aims to evaluate whether such a tool could be useful in treating persistent traumatic brain
      injury symptoms such as inattention, impulsivity, irritability, or dysregulated mood.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty subjects in total will participate in this study. Subjects will be randomized to
      focused-attention meditation training with or without the neurofeedback device, MUSE.
      Subjects will be asked to practice ~10 min of daily meditation for 6-8 weeks.
      Neuropsychological testing will be performed at the beginning of the study and after six
      weeks of training. At this time point, those randomized to the non-MUSE group will be given a
      device and asked to train for an additional two weeks. At the conclusion of the study, all
      subjects will also undergo a brief telephone or in-person exit interview regarding their
      experiences using the MUSE device.

      Primary endpoint: change in Neurobehavioral Symptom Inventory

      Secondary endpoints: change in the following: Wechsler Adult Intelligence Scale-IV Digit Span
      and Symbol-Digit Coding, Trail-Making Test, Beck Anxiety Inventory, Beck Depression
      Inventory, Cognitive and Affective Mindfulness Scale-Revised, percentage of EEG activity
      associated with alpha, beta, or theta activity.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Neurobehavioral Symptom Inventory</measure>
    <time_frame>baseline and six weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in Wechsler Adult Intelligence Scale-IV Digit Span</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Wechsler Adult Intelligence Scale-IV Digit Symbol Coding</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Trail Making Test</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Beck Anxiety Inventory</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Beck Depression Inventory-II</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in Cognitive and Affective Mindfulness Scale-Revised</measure>
    <time_frame>baseline and six weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in percentage of EEG activity associated with alpha, beta, and theta rhythms as measured by surface electrodes on the MUSE device</measure>
    <time_frame>baseline, throughout intervention, and at six weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>EEG neurofeedback-assisted meditation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG neurofeedback assisted meditation using the MUSE device and auditory feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-EEG feedback-assisted meditation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-EEG neurofeedback assisted meditation. Subjects will have auditory instruction from the MUSE device without the EEG neurofeedback.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG neurofeedback-assisted meditation</intervention_name>
    <description>meditation with auditory feedback regarding EEG status</description>
    <arm_group_label>EEG neurofeedback-assisted meditation</arm_group_label>
    <other_name>MUSE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-EEG feedback-assisted meditation</intervention_name>
    <description>meditation without auditory feedback regarding EEG status</description>
    <arm_group_label>Non-EEG feedback-assisted meditation</arm_group_label>
    <other_name>MUSE without EEG feedback</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. history of mild-moderate traumatic brain injury

          2. impaired attention or concentration

          3. &gt;1 year since traumatic brain injury

          4. ability to participate in neurofeedback and mindfulness meditation

          5. daily access to a smart phone

          6. on stable dosage of neuropsychological medications with no significant changes planned
             for the duration of the study

          7. no prior history of a meditation practice

        Exclusion Criteria:

          1. severe mental illness or psychological symptoms (severe depression, suicidality,
             disabling anxiety, PTSD, psychosis, dissociation)

          2. significant pre-morbid learning disability

          3. current or recent (in past year) history of significant drug or alcohol abuse

          4. medical illness severe enough to result in an attentional disorder

          5. neurodegenerative disease

          6. non-fluency in English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mel B Glenn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spaulding Rehabilitation Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spaulding Rehabilitation Hospital Boston</name>
      <address>
        <city>Charlestown</city>
        <state>Massachusetts</state>
        <zip>02129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brandmeyer T, Delorme A. Meditation and neurofeedback. Front Psychol. 2013 Oct 7;4:688. doi: 10.3389/fpsyg.2013.00688. eCollection 2013.</citation>
    <PMID>24109463</PMID>
  </reference>
  <reference>
    <citation>Chiesa A, Calati R, Serretti A. Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev. 2011 Apr;31(3):449-64. doi: 10.1016/j.cpr.2010.11.003. Epub 2010 Dec 1. Review.</citation>
    <PMID>21183265</PMID>
  </reference>
  <reference>
    <citation>Cicerone KD, Langenbahn DM, Braden C, Malec JF, Kalmar K, Fraas M, Felicetti T, Laatsch L, Harley JP, Bergquist T, Azulay J, Cantor J, Ashman T. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil. 2011 Apr;92(4):519-30. doi: 10.1016/j.apmr.2010.11.015. Review.</citation>
    <PMID>21440699</PMID>
  </reference>
  <reference>
    <citation>Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010 Apr;78(2):169-83. doi: 10.1037/a0018555.</citation>
    <PMID>20350028</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spaulding Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Mel B. Glenn</investigator_full_name>
    <investigator_title>Director of Outpatient and Community Brain Injury Rehabilitation</investigator_title>
  </responsible_party>
  <keyword>traumatic brain injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>If participants request their outcome data, we will provide this to them with a brief discussion of its meaning and limitations on interpretation.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

